Anti-coagulant drug could treat COVID-19"s emerging variants
Molecules from the same family as the anti-coagulant drug heparin may interfere with the ability of the COVID-19 virus's spikes to bind to human cells. This could be used to treat people with severe effects of the virus and any emerging variants......»»
Space business is evolving fast—a new book provides much-needed insight
Space Business: Emerging Theory and Practice, a new book edited by Professor Arto Ojala, Professor of International Business at the University of Vaasa, Finland, and Professor William W. Baber, University of Kyoto, examines the space business, its bu.....»»
Study unveils cobalt(III) reaction mechanism with nitriles, opening pathways for drug development
A research team led by Professor Jaeheung Cho from the Department of Chemistry at UNIST has published a study in the Journal of the American Chemical Society reporting the reaction mechanism of cobalt(III)-based metal complexes with nitrile substance.....»»
On US coast, wind power foes embrace "Save the Whales" argument
Whether from real concern for marine animals or doubts about renewable energy, the anti-wind power movement has been growing along the US East Coast, with some trying to blame a surge in whale strandings on the growth of offshore energy projects......»»
Is COVID-19 infecting wild animals? Researcher test species from bats to seals to find out
Over the course of the COVID-19 pandemic, researchers have found coronavirus infections in pet cats and dogs and in multiple zoo animals, including big cats and gorillas. These infections have even happened when staff were using personal protective e.....»»
watchTowr raises $19 million to accelerate global growth
watchTowr announced a $19 million Series A funding round led by Peak XV, formerly known as Sequoia India & Southeast Asia, with repeat participation from Prosus Ventures and Cercano Management. The company will use the funds to capture market leaders.....»»
Drug makers can’t make knockoff weight-loss drugs anymore—and they’re mad
Compounding pharmacies could make knockoffs during shortage. But FDA says it's over. Compounding pharmacies are suing the Food and Drug Administration so they can keep making imit.....»»
Amazon partners with the NFL to launch limited-edition Echo Pops
Amazon is releasing an Echo Pop lineup featuring all 32 NFL teams. These will be released in groups from now until November 19. They're priced at $60 each......»»
Making micelles more effective for dye and drug dispersion through well-defined core-shell structures
Micelles are spherical molecular structures usually formed by amphiphilic molecules with block structure, which contain both hydrophilic and hydrophobic parts. The hydrophobic tails of these molecules cluster together to form a core, while the hydrop.....»»
Upcoming premium Ring doorbell subscription offers AI search – with mixed results
An upcoming premium Ring doorbell subscription will offer 24/7 recording, and AI-powered search, from $19.99 per month. The Amazon-owned company is also renaming two of its existing subscription tiers, while Ring Protect Pro subscribers will have.....»»
A Major GLP-1 Drug Shortage Is Over. Some Patients Aren’t Celebrating
Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded versions of these GLP-1 medications, it’s a complicated situation......»»
Researchers discover how plants produce a novel anti-stress molecule
New research identifies for the first time the genes that help plants grow under stressful conditions—with implications for producing more sustainable food crops in the face of global climate change......»»
Scientists discover novel series of SARS-CoV-2 Mpro inhibitors for potential new COVID-19 treatments
New research from The Wistar Institute's Salvino lab, led by professor Joseph Salvino, Ph.D., has identified a novel series of SARS-CoV-2 Mpro inhibitors that may lead to potential new COVID-19 treatments that—according to preclinical testing—eff.....»»
Researchers design a drug capable of acting simultaneously against three different therapeutic targets
A study led by researchers of the Institute of Biomedicine of the University of Barcelona (IBUB) has developed a new pharmacological tool capable of simultaneously administering three oligonucleotide-based drugs, each acting against a different thera.....»»
Research team develops metallodrug-antibiotic combination strategy to combat superbugs
Antimicrobial resistance (AMR) bacterial infections have become a serious problem threatening human health worldwide. The overuse of antibiotics has promoted drug-resistant mutations in bacteria, causing almost all clinically used antibiotics to deve.....»»
Anti-glitches detected in gamma-ray pulsar PSR J1522-5735
By analyzing the data from NASA's Fermi Gamma-ray Space Telescope, Russian astronomers have detected anti-glitches in a gamma-ray pulsar designated PSR J1522-5735. The discovery, published September 28 on the pre-print server arXiv, makes PSR J1522-5.....»»
Artificial proteasome offers insights for new trichomoniasis treatments
Researchers from IOCB Prague are furthering the understanding of how medicines work and what it takes to develop their most effective variants. In one current study, they have focused on the disease caused by the protozoan parasite Trichomonas vagina.....»»
AI and quantum mechanics team up to accelerate drug discovery
Drug discovery is much like working a jigsaw puzzle. The chemical compounds behind drug molecules must be shaped to fit with the proteins in our bodies to produce therapeutic effects. That requirement for a meticulous fit means the creation of new dr.....»»
Singapore families show high resilience during pandemic
A recent study by the National University of Singapore Yong Loo Lin School of Medicine (NUS Medicine) analyzing the resilience of Singaporean families during the COVID-19 pandemic has uncovered significant findings that highlight how most families wi.....»»
CDK notifies Maine about June 19 cyberattack data breach
CDK's breach notification with the Maine Attorney General's Office appears to be the first since the June 19 cyberattacks......»»
SCOTUS denial ends saga of Shkreli’s infamous 5,000% drug price scheme
The Supreme Court offered no explanation for denying the petition. The legal saga over Martin Shkreli's infamous 5,000 percent price hike of a life-saving anti-parasitic drug has.....»»